157 related articles for article (PubMed ID: 32979908)
1. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
2. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
Huang HB; Jiang SC; Han J; Cheng QS; Dong CB; Pan CM
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
[TBL] [Abstract][Full Text] [Related]
4. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
Seo MS; Yeo J; Hwang IC; Shim JY
Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
[TBL] [Abstract][Full Text] [Related]
5. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
Dai X; Fang X; Ma Y; Xianyu J
Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.
Ou J; Zhen K; Wu Y; Xue Z; Fang Y; Zhang Q; Bi H; Tian X; Ma L; Liu C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9517-9528. PubMed ID: 37213031
[TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
8. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
[TBL] [Abstract][Full Text] [Related]
9. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
[TBL] [Abstract][Full Text] [Related]
10. Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis.
Wang J; Liu J; Pan L; Guo L; Liu C; Yang S
Lupus; 2021 Apr; 30(5):725-733. PubMed ID: 33557684
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
12. Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies.
Huang TB; Guo ZF; Zhang XL; Zhang XP; Liu H; Geng J; Yao XD; Zheng JH
Int Urol Nephrol; 2014 Aug; 46(8):1481-93. PubMed ID: 24677003
[TBL] [Abstract][Full Text] [Related]
13. Association of atopic dermatitis with an increased risk of systemic lupus erythematosus: A systematic review and meta-analysis.
Ponvilawan B; Charoenngam N; Wongtrakul W; Ungprasert P
J Postgrad Med; 2021; 67(3):139-145. PubMed ID: 34427279
[TBL] [Abstract][Full Text] [Related]
14. Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study.
Chevet B; Figueroa-Parra G; Yang JX; Hocaoglu M; Osei-Onomah SA; Hulshizer CA; Gunderson TM; Cornec D; Barbour KE; Greenlund KJ; Crowson CS; Duarte-García A
Arthritis Res Ther; 2022 Sep; 24(1):211. PubMed ID: 36050780
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
Chen Y; Fu L; Pu S; Xue Y
Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies.
Wei S; Lai K; Yang Z; Zeng K
Lupus; 2017 May; 26(6):563-571. PubMed ID: 28121241
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis.
Guan SY; Cai HY; Wang P; Lv TT; Liu LN; Mao YM; Zhao CN; Wu Q; Dan YL; Sam NB; Wang DG; Pan HF
Int J Rheum Dis; 2019 Oct; 22(10):1803-1813. PubMed ID: 31468723
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis.
Wu Y; Hou Q
J Cancer Res Ther; 2016; 12(2):721-4. PubMed ID: 27461640
[TBL] [Abstract][Full Text] [Related]
20. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
